'I donated mum's body to Alzheimer's research what happened next was horrifying'
Her son said 'she was strapped in a chair, and a detonation took place underneath her'
One Arizona man thought he was donating his mother's body to science after her harrowing descent in Alzheimer's - only to discover he had been sent her cremated arm before the rest of her body was strapped to a chair and blown up.
Jim Stauffer cared for his mother Doris throughout her illness before she died at 74 in 2013. He decided to donate her brain to science hoping to contribute to a cure for Alzheimer's disease. The family contacted Biological Resource Center, a local company that brokered the donation of human bodies for research. Within the hour, BRC dispatched a driver to collect Doris.
Jim signed a form authorising medical research on his mother's body. Ten days later, Jim received his mother's cremated remains - but it turns out her ashes were made up of a singular arm sawn off from her body. The rest of her corpse had met a violent fate.
Doris' brain never was used for Alzheimer's research. Instead, her body became part of an Army experiment to measure damage caused by roadside bombs, the Irish Star reports.
Internal BRC and military records show that at least 20 other bodies were also used in the blast experiments without permission of the donors or their relatives, a violation of U.S. Army policy. Jim had also ticked a box specifically banning any kind of experiments on Doris. BRC sold donated bodies like Stauffer's for $5,893 each.
Jim said: "She was strapped in a chair, and a detonation took place underneath her to get an idea of what the human body goes through when a vehicle is hit by an IED. There was wording on this paperwork about performing tests that may involve explosions, and we said, 'No'."
Army officials involved in the project said they never received the consent forms that donors or their families had signed. Rather, the officials said they relied on assurances from BRC that families had agreed to let the bodies be used in such experiments.
BRC, which sold more than 20,000 parts from some 5,000 human bodies over a decade, is no longer in business. Its former owner, Stephen Gore, pleaded guilty to fraud in 2022.
In a statement to Reuters, Gore said that he always tried to honor the wishes of donors and sent consent forms when researchers requested them. Jim said of Gore "He didn't care about the families, he didn't care about the people."
Jim learned of the fate of his mother's body from a Reuters reporter and "curled his lip in anger and clutched his wife Lisa's arm. "We did right," Lisa reassured him. "They just did not honor our wishes."
No federal law regulates body brokers like BRC, and no U.S. government agency monitors what happens to cadavers pledged for use in medical education and research.
"It is not illegal to sell a whole body or the parts of a body for research or education," said University of Iowa law professor Sheldon F. Kurtz, who helped modify the Uniform Anatomical Gift Act, which has been adopted by 46 states. Although the act was updated in 2006, Kurtz said, "the issue of whole bodies or body parts for research or education never came up during our discussions."
Since then, the body trade has become big business. Only one state, New York, keeps detailed records on the industry.
According to the most recent data available, companies that did business in New York shipped at least 100,000 body parts across the country from 2011 to 2014. Reuters obtained the data, which have never been made public, from the state's health department.
"I feel foolish," said Jim. "I'm not a trusting person, but, you have no idea this is going on." Military officials said they took BRC's word that permission had been given. Records show at least 20 more bodies were blown up without consent.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
3 minutes ago
- Reuters
Metsera rises as experimental weight-loss drug shows promise in small early-stage trial
June 9 (Reuters) - Shares of weight-loss drug developer Metsera (MTSR.O), opens new tab gained as much as 25% on Monday after the company's experimental drug helped patients lose weight in a small, early-stage trial, showing potential for a monthly dosing regime. The drug developer, which went public in January, is one of the many that are eyeing the lucrative market of weight-loss drugs that have been dominated by GLP-1 drugs from Novo Nordisk ( opens new tab and Eli Lilly (LLY.N), opens new tab. The drug, MET-233i, helped patients lose 8.4% of their weight, when adjusted for placebo, at 36 weeks. The drug belongs to a class of medicines which mimic the pancreatic hormone amylin that is co-secreted with insulin. It is being developed as a standalone treatment, and in combination with the company's other GLP-1 drug MET-097i. The two hormones combined suppress hunger, help control patients' blood glucose. Metsera's shares, which touched $35.19 in early trading, were up 5% at midday. The first wave of obesity drugs was based mainly on the gut hormone GLP-1, but drugmakers are looking for medicines that target other hormones or help preserve muscle while losing fat for their next generation of drugs. Data from Novo Nordisk's experimental drug CagriSema, which was touted to be the successor of its blockbuster obesity drug Wegovy, has so far fallen below investor expectations. Data from Metsera's 80-patient study showed that its drug has a half life of about 19 days, supporting once-a-month dosing. This compares to the five to seven days for Lilly's Zepbound and Novo's Wegovy that are taken weekly, said Evercore ISI analyst Umer Raffat. The so-called half life of a drug refers to the time it takes for the initial dose of the medicine to decrease by half in a patient's body. It helps determine how frequently a drug should be taken to achieve benefits. Drugmaker AstraZeneca (AZN.L), opens new tab is also testing an amylin-based obesity drug in early trials.
Medical News Today
22 minutes ago
- Medical News Today
Dementia: Switching to MIND diet even later in life can lower risk
MIND diet lowers dementia risk, even if you start it later in life, a new study has found. Image credit: istetiana/Getty Images. As of 2021, about 57 million people around the world were living with dementia, with 60–70% of those cases being Alzheimer's disease. In 2015, researchers at Rush University Medical Center developed the MIND diet. Since then, multiple studies have linked this eating pattern to a reduced risk of dementia. A new study says that following the MIND diet may help lower a person's risk for developing dementia, including Alzheimer's disease, even if they don't start following the diet until later in life. These benefits were especially seen in participants who identified as African-American, Latino, or white. Past studies have shown that certain lifestyle changes — such as following a healthy diet — may help lower a person's risk for developing dementia. With its emphasis on brain-healthy foods, past studies have suggested that following the MIND diet may decrease a person's risk for cognitive impairment, more generally, and dementia and mortality , more specifically. Now, a new study presented at NUTRITION 2025, the flagship annual meeting of the American Society for Nutrition, reports that following the MIND diet may help lower a person's risk for developing dementia and Alzheimer's disease, even if they don't start following the diet until later in life. These benefits were especially seen in participants who identified asAfrican American, Latino, or white. The study is yet to undergo peer review and appear in a specialised journal. For this study, researchers analyzed dietary data from almost 93,000 U.S. adults between the ages of 45 to 75, who participated in the Multiethnic Cohort Study, which began in the 1990s. Participants were from five racial and ethnic groups — African American, Latino, white, Native Hawaiian, and Asian American. Scientists scored each participant's adherence to MIND diet principles based on a food frequency questionnaire provided at the start of the study and again 10 years later. 'The MIND diet includes 10 brain-healthy and 5 brain-unhealthy food groups,' Song-Yi Park, PhD, associate professor of the Population Sciences in the Pacific Program at the University of Hawaii Cancer Center and lead author of this study told Medical News Today . 'We calculated the MIND diet score using Morris' methods in the Multiethnic Cohort Study. We examined several healthy dietary patterns and found more consistent results with the MIND diet compared to other dietary patterns, such as the Mediterranean, DASH, and Healthy Eating Index.' At the study's conclusion, Park and her team found that study participants with the highest MIND diet scores at the start of the study had a 9% lower risk of developing dementia. That reduced risk rate jumped to 13% for participants identifying as white, Latino, or African American. 'Previous studies were mostly conducted in White populations,' Park explained. 'Our study confirms the protective association in a more diverse population. We have no clear explanation for the observed racial/ethnic heterogeneity. Differences in dietary patterns and preferences could play a role. Also, the MIND diet may not fully capture the benefits of ethnic diets.' Scientists also discovered that study participants who improved their adherence to the MIND diet over 10 years — including those who at first did not closely follow this dietary pattern — decreased their dementia risk by 25%, compared to those whose MIND diet compliance declined. 'Our study findings confirm that healthy dietary patterns in mid to late life and their improvement over time may prevent Alzheimer's and related dementias,' Park said in a press release. 'This suggests that it is never too late to adopt a healthy diet to prevent dementia.' Since the burden of dementia is increasing and the pharmacological treatments are still very limited, Park said reducing modifiable risk factors to prevent the disease is a public health priority. 'Improving diet quality at older ages is still beneficial for preventing dementia,' she continued. 'We plan to explore individual dietary components that can better capture ethnically tailored healthy dietary patterns and optimal intake levels.' MNT had the opportunity to speak with Clifford Segil, DO, a neurologist in private practice in Santa Monica, CA, and on staff at Providence St. John's Health Center, about this study. 'I wish I agreed that leafy green vegetables, berries, nuts, and olive oil were proven brain healthy foods as these are definitely healthy for your heart, but less clearly for your brain,' Segil, who was not involved in the research, commented. He explained that eating healthy throughout your life can help reduce your risk of diabetes, hyperlipidemia, obesity, and first-time heart attacks and strokes. But, he suggested, 'it is less clear if healthy eating can protect elderly patients from getting dementia.' 'Modifiable risk factors medicine allow physicians to give advice to patients to prevent disease and avoid medications,' Segil continued. 'We have no clearly proven modifiable risk factors in life to prevent the onset of memory loss as we age or dementia at this time. 'I would like to see that the proposed MIND diet had any significant impact on a patient's blood pressure, blood glucose, or serum lipid profile,' Segil added. 'I would like to see if the MIND diet causes changes to routine lab tests physicians follow in their annual physical exams on patients.' Monique Richard, MS, RDN, LDN, a registered dietitian nutritionist and owner of Nutrition-In-Sight, offered MNT her top tips for those who may want to try the MIND diet. 'Before implementing, be sure to meet with a registered dietitian nutritionist (RDN) to understand further how these dietary patterns may, or may not, be beneficial to your needs, goals, preferences, ability to access, culinary literacy and cultural heritage,' Richard advised. She said that individuals could consider adding these MIND diet components fairly easily to their current diet, depending on access, for nutrient dense choices bursting with flavor, texture and versatility: berries, such as strawberries, wild blueberries, raspberries, cherries, blackberries, elderberries leafy greens, including kale, spinach, turnip greens, collard greens, romaine lettuce, microgreens, mustard greens, arugula — these can be added to smoothies, sautéed dishes, stir-fry, soups, or eaten raw with each meal, aiming for 6 to 9 servings in a week nuts and seeds like pistachios, pecans, walnuts, almonds, Brazil nuts, hazelnuts, cashews, pumpkin seeds, sunflower seed kernels, chia seeds, flaxseeds — added to snacks, muffins, oatmeal, sandwiches, or salads Beans, such as kidney, lima, black beans, navy bean, garbanzo beans, or even lentils, legumes (like peanuts), and soybeans (edamame, fermented tofu) — aim for 4 to 6 meals per week that include beans non-starchy vegetables, such as onions, peppers, tomatoes, cucumbers, radishes, beets, and carrots — eaten more often in addition to leafy greens whole grains like oats, whole rye, rice, buckwheat, farro, sorghum — incorporated into meals, at least 3 servings of these a day cold water fatty fish — 4–6 ounces per serving, two to three times a week olive oil — ideally high-quality, extra-virgin, cold-pressed olive oil in cooked dishes. Richard suggested: 'Be mindful — consider asking yourself what […] your meals look like on a daily basis in comparison to these recommended components. Do you know how to shop for, prepare, or consume these foods? Are you able to access a variety of these foods? What other tools may be helpful for you to incorporate these into your life?' 'Feed your mind — following dietary patterns such as the MIND diet are only part of the equation,' she also advised. Alzheimer's / Dementia Neurology / Neuroscience Nutrition / Diet
Scottish Sun
40 minutes ago
- Scottish Sun
The 52p herb that could help prevent Alzheimer's – plus 3 other ways it can benefit your health
Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) KNOWN for its strong, pine-like flavour and its use in various dishes, rosemary has a lot more going for it than its scent and taste. The popular herb is starting to gain recognition for its impressive health benefits, especially when it comes to brain health, inflammation and immune function. Sign up for Scottish Sun newsletter Sign up 2 Rosemary has been shown to benefit the brain in several ways Credit: Getty And research published this year suggests it could even help in the fight against Alzheimer's disease - the leading cause of dementia worldwide. Rosemary has previously been linked to memory and mental clarity. In ancient Greece and Rome, students and scholars used rosemary to sharpen concentration and recall, says Dipa Kamdar, senior lecturer in pharmacy practice at Kingston University. Writing for The Conversation, she explains: "Modern science is finding there may have been something in this: in one study, people who inhaled rosemary's scent performed better on memory takes compared to those in an unscented environment." There are several ways rosemary benefits the brain, says Kamdar. Firstly, it stimulates blood circulation, including to the brain, helping deliver more oxygen and nutrients, which may improve mental clarity. It also has calming properties, with some studies suggesting its aroma can reduce anxiety and improve sleep - lower stress means better focus and memory retention. Kamdar adds: "Rosemary contains compounds that interact with the brain's neurotransmitters. One such compound, 1,8-cineole, helps prevent the breakdown of acetylcholine, a brain chemical essential for learning and memory. By preserving acetylcholine, rosemary may help support cognitive performance, especially as we age." And rosemary's antioxidants may also help protect brain cells from damage caused by oxidative stress - which is a major factor in cognitive decline. Kamdar says: " Rosemary is rich in phytochemicals, plant compounds with health-enhancing effects. One of the most powerful is carnosic acid, an antioxidant and anti-inflammatory agent that helps shield brain cells from harm, particularly from the kinds of damage linked to Alzheimer's disease." Five simple tests that could indicate dementia What are rosemary's benefits beyond brain health? 2 Rosemary may aid digestion by stimulating the liver to produce bile Credit: Getty As well as boosting brain health, studies suggest rosemary may aid digestion by stimulating the liver to produce bile, which helps the body digest fat. In a study with mice, it was shown to reduce inflammation in the digestive tract, potentially aiding in the management of IBS and other inflammatory bowel ailments. And rosemary supplementation may also positively impact the gut microbiota, increasing beneficial bacteria like Bifidobacterium and Bacteroidetes, while reducing harmful bacteria like Escherichia coli. Rosemary may also be able to improve immune function. Some studies, particularly in vitro and animal models, suggest that rosemary and its active compounds, like carnosic acid and rosmarinic acid, can influence immune function. Other studies have shown rosemary may promote immune cell activity, such as increasing antibody production or enhancing the activity of immune cells like dendritic cells. Finally, rosemary could prevent certain cancers. Rosemary has been proven to display powerful anticancer efficacy in numerous cancers, including lung, prostate, liver, and breast. Carnosic acid appears to be the plant's primary anticancer component, as it was found in one study to exhibit antiproliferative effects in cancer cells.
